Xiaohan Xu

956 total citations · 1 hit paper
30 papers, 715 citations indexed

About

Xiaohan Xu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Xiaohan Xu has authored 30 papers receiving a total of 715 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Cancer Research. Recurrent topics in Xiaohan Xu's work include Heme Oxygenase-1 and Carbon Monoxide (4 papers), Neonatal Health and Biochemistry (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Xiaohan Xu is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (4 papers), Neonatal Health and Biochemistry (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Xiaohan Xu collaborates with scholars based in China, Netherlands and Norway. Xiaohan Xu's co-authors include Junhong Wang, Yixing Du, Ming Chu, Yan Guo, Xiaowei Wang, Xiaowei Wang, Bingwei Sun, Lei Xue, Linjie Si and Jing Xu and has published in prestigious journals such as The Science of The Total Environment, International Journal of Molecular Sciences and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Xiaohan Xu

28 papers receiving 702 citations

Hit Papers

Air particulate matter and cardiovascular disease: the ep... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohan Xu China 12 327 183 91 78 74 30 715
Ming Chu China 12 324 1.0× 190 1.0× 91 1.0× 76 1.0× 46 0.6× 23 760
Xue Jiang China 17 527 1.6× 248 1.4× 204 2.2× 100 1.3× 68 0.9× 49 1.2k
Ni Bai Canada 15 482 1.5× 109 0.6× 124 1.4× 144 1.8× 35 0.5× 26 834
Selitá Lucas United States 16 537 1.6× 105 0.6× 108 1.2× 103 1.3× 38 0.5× 30 874
Alfredo Nunziata Italy 12 348 1.1× 82 0.4× 110 1.2× 88 1.1× 67 0.9× 24 693
Antonella Fiordelisi Italy 15 284 0.9× 251 1.4× 88 1.0× 66 0.8× 46 0.6× 32 965
Yaqi Li China 18 272 0.8× 152 0.8× 63 0.7× 133 1.7× 101 1.4× 75 912
Yan Guo China 20 334 1.0× 463 2.5× 92 1.0× 79 1.0× 162 2.2× 80 1.5k
Xiaoming Song China 22 720 2.2× 178 1.0× 226 2.5× 109 1.4× 72 1.0× 75 1.3k
Xihao Du China 18 618 1.9× 132 0.7× 166 1.8× 90 1.2× 20 0.3× 49 818

Countries citing papers authored by Xiaohan Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaohan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohan Xu more than expected).

Fields of papers citing papers by Xiaohan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohan Xu. The network helps show where Xiaohan Xu may publish in the future.

Co-authorship network of co-authors of Xiaohan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohan Xu. A scholar is included among the top collaborators of Xiaohan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohan Xu. Xiaohan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Huizhong, Xiaohan Xu, Wenjing Li, et al.. (2025). Advances in nanoplatform-based multimodal combination therapy activating STING pathway for enhanced anti-tumor immunotherapy. Colloids and Surfaces B Biointerfaces. 250. 114573–114573. 2 indexed citations
2.
Zhang, Huizhong, Xiaohan Xu, Wenqi Wang, et al.. (2025). A novel biomimetic nanoplatform amplifies ferroptosis for specific cGAS-STING pathway activation to enhance hepatocellular carcinoma chemo-immunotherapy. Journal of Nanobiotechnology. 23(1). 799–799.
3.
Fan, Yifan, Shuo Wang, Xiaohan Xu, et al.. (2024). Integration of interpretable machine learning and environmental magnetism elucidates reduction mechanism of bioavailable potentially toxic elements in lakes after monsoon. The Science of The Total Environment. 954. 176418–176418. 2 indexed citations
4.
Fu, Jing, Yuanyuan He, Huizhong Zhang, et al.. (2024). Co-delivery of polyphyllin II and IR780 PLGA nanoparticles induced pyroptosis combined with photothermal to enhance hepatocellular carcinoma immunotherapy. Journal of Nanobiotechnology. 22(1). 647–647. 11 indexed citations
5.
Xu, Xiaohan, Jinxu Zhang, Hongxiao Liu, Zhe Zhao, & Junyi Jiang. (2024). Intervention of inflammation associated with ankylosing spondylitis by triptolide promotes histone H3 Iys-27 trimethylation. Immunopharmacology and Immunotoxicology. 46(6). 785–792. 1 indexed citations
6.
Zhang, Yibo, et al.. (2024). [Anti-tumor mechanism of total saponins of Paridis Rhizoma on inducing ferroptosis of breast cancer MCF-7 cells].. PubMed. 49(9). 2385–2392. 2 indexed citations
8.
Liu, Xiaoxin, Miaomiao Song, Yingying Zhou, et al.. (2020). Aberrant Exon 8/8a Splicing by Downregulated PTBP (Polypyrimidine Tract-Binding Protein) 1 Increases Ca V 1.2 Dihydropyridine Resistance to Attenuate Vasodilation. Arteriosclerosis Thrombosis and Vascular Biology. 40(10). 2440–2453. 9 indexed citations
9.
Xu, Xiaohan, Junhong Wang, & Xiaowei Wang. (2020). Silencing of circHIPK3 Inhibits Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction by Sponging miR-185-3p. Drug Design Development and Therapy. Volume 14. 5699–5710. 28 indexed citations
10.
Liu, Yishu, Xu Wang, Xiaohan Xu, Weiting Qin, & Bingwei Sun. (2019). Carbon monoxide releasing molecule‑2 (CORM‑2)‑liberated CO ameliorates acute pancreatitis. Molecular Medicine Reports. 19(6). 5142–5152. 11 indexed citations
11.
Xu, Xiaohan, Shuyun Zheng, Yuyun Xiong, et al.. (2017). Adenosine effectively restores endotoxin-induced inhibition of human neutrophil chemotaxis via A1 receptor-p38 pathway. Inflammation Research. 66(4). 353–364. 15 indexed citations
12.
Ma, Yue, et al.. (2016). Valsartan Protects Against Contrast-Induced Acute Kidney Injury in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis. Current Vascular Pharmacology. 15(2). 174–183. 13 indexed citations
13.
Du, Yixing, Xiaohan Xu, Ming Chu, Yan Guo, & Junhong Wang. (2016). Air particulate matter and cardiovascular disease: the epidemiological, biomedical and clinical evidence.. PubMed. 8(1). E8–E19. 397 indexed citations breakdown →
14.
Xu, Xiaohan & Bingwei Sun. (2015). Platelet granule secretion mechanisms: Are they modified in sepsis?. Thrombosis Research. 136(5). 845–850. 10 indexed citations
15.
Si, Linjie, Jing Xu, Xiaohan Xu, et al.. (2015). Asiatic Acid Attenuates the Progression of Left Ventricular Hypertrophy and Heart Failure Induced by Pressure Overload by Inhibiting Myocardial Remodeling in Mice. Journal of Cardiovascular Pharmacology. 66(6). 558–568. 16 indexed citations
16.
Xue, Lei, Xiaowei Wang, Jing Xu, et al.. (2012). ISL1 Common Variant rs1017 Is Not Associated with Susceptibility to Congenital Heart Disease in a Chinese Population. Genetic Testing and Molecular Biomarkers. 16(7). 679–683. 9 indexed citations
17.
Zhang, Yangyang, Xiaowei Wang, Xiaohan Xu, et al.. (2012). Distinct microRNA expression signatures in human right atrial and ventricular myocardium. Molecular and Cellular Biochemistry. 371(1-2). 23–29. 4 indexed citations
18.
Cao, Hailong, Lei Xue, Xiaohan Xu, et al.. (2011). Heat shock proteins in stabilization of spontaneously restored sinus rhythm in permanent atrial fibrillation patients after mitral valve surgery. Cell Stress and Chaperones. 16(5). 517–528. 27 indexed citations
19.
Zhou, Yujie, Xiaomin Nie, Miao Yu, et al.. (2011). Rapamycin Affects Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 Expression. Angiology. 63(5). 330–335. 10 indexed citations
20.
Xu, Jing, Xiaohan Xu, Lei Xue, et al.. (2010). MTHFR c.1793G>A polymorphism is associated with congenital cardiac disease in a Chinese population. Cardiology in the Young. 20(3). 318–326. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026